
Mauna Kea Technologies Investor Relations Material
Latest events

Q2 2023 TU
Mauna Kea Technologies
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Mauna Kea Technologies SA
Access all reports
Mauna Kea Technologies SA is a French medical device company that specializes in developing and marketing advanced optical biopsy systems. The company's flagship product, Cellvizio, is a probe-based Confocal Laser Endomicroscopy (pCLE) platform. This technology allows physicians to obtain real-time, high-resolution cellular images during endoscopic procedures, primarily for detecting abnormalities in the gastrointestinal and pulmonary tracts, particularly in cancer patients. The Cellvizio system is designed to improve diagnostic accuracy and support more immediate treatment decisions, with applications across multiple medical specialties. Mauna Kea Technologies is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ALMKT
Country
🇫🇷 France